Insights

Novel Integrin Therapies Morphic Therapeutic is developing oral integrin therapies for immunological, fibrotic, neoplastic, and vascular diseases, offering a unique selling point in the pharmaceutical market.

Pipeline Expansion Recent news indicates Morphic is expanding its preclinical pipeline to develop molecules for autoimmune diseases, pulmonary hypertension, fibrotic diseases, and cancer, presenting diverse opportunities for partnership and product sales.

Strategic Hires The appointment of key personnel such as Simon Cooper as Chief Medical Officer showcases Morphic's commitment to driving innovation, potentially opening avenues for collaboration and product adoption in the medical community.

Competitive Landscape Being in a competitive market with companies of similar size and revenue, Morphic's focus on integrins and novel treatments positions it uniquely for differentiation and market competitiveness.

Financial Strength With substantial funding of $276 million and revenue in the range of $10-50 million, Morphic has the financial backing to support partnerships and investments, presenting a stable ground for long-term collaborations.

Morphic Therapeutic Tech Stack

Morphic Therapeutic uses 8 technology products and services including Amazon Web Services, CIVIC, Module Federation, and more. Explore Morphic Therapeutic's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • CIVIC
    Cookie Compliance
  • Module Federation
    Development
  • Modernizr
    Javascript Libraries
  • X-XSS-Protection
    Security
  • HSTS
    Security
  • Adobe Fonts
    Web Fonts
  • Apache
    Web Servers

Media & News

Morphic Therapeutic's Email Address Formats

Morphic Therapeutic uses at least 1 format(s):
Morphic Therapeutic Email FormatsExamplePercentage
First.Last@morphictx.comJohn.Doe@morphictx.com
93%
FirstMiddle.Last@morphictx.comJohnMichael.Doe@morphictx.com
3%
Last@morphictx.comDoe@morphictx.com
2%
LastF@morphictx.comDoeJ@morphictx.com
2%

Frequently Asked Questions

Where is Morphic Therapeutic's headquarters located?

Minus sign iconPlus sign icon
Morphic Therapeutic's main headquarters is located at 35 Gatehouse Drive, A2, Waltham, MA 02451 Waltham, MA 02451, US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Morphic Therapeutic's phone number?

Minus sign iconPlus sign icon
You can contact Morphic Therapeutic's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Morphic Therapeutic's official website and social media links?

Minus sign iconPlus sign icon
Morphic Therapeutic's official website is morphictx.com and has social profiles on LinkedInCrunchbase.

How much revenue does Morphic Therapeutic generate?

Minus sign iconPlus sign icon
As of June 2025, Morphic Therapeutic's annual revenue reached $35M.

What is Morphic Therapeutic's NAICS code?

Minus sign iconPlus sign icon
Morphic Therapeutic's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Morphic Therapeutic have currently?

Minus sign iconPlus sign icon
As of June 2025, Morphic Therapeutic has approximately 61 employees across 3 continents, including North AmericaEuropeAsia. Key team members include CEO: P. T.Chief Scientific Officer: B. L.Chief Financial Officer: M. S.. Explore Morphic Therapeutic's employee directory with LeadIQ.

What industry does Morphic Therapeutic belong to?

Minus sign iconPlus sign icon
Morphic Therapeutic operates in the Pharmaceutical Manufacturing industry.

What technology does Morphic Therapeutic use?

Minus sign iconPlus sign icon
Morphic Therapeutic's tech stack includes Amazon Web ServicesCIVICModule FederationModernizrX-XSS-ProtectionHSTSAdobe FontsApache.

What is Morphic Therapeutic's email format?

Minus sign iconPlus sign icon
Morphic Therapeutic's email format typically follows the pattern of . Find more Morphic Therapeutic email formats with LeadIQ.

How much funding has Morphic Therapeutic raised to date?

Minus sign iconPlus sign icon
As of June 2025, Morphic Therapeutic has raised $276M in funding. The last funding round occurred on May 03, 2023 for $276M.

When was Morphic Therapeutic founded?

Minus sign iconPlus sign icon
Morphic Therapeutic was founded in 2015.
Morphic Therapeutic

Morphic Therapeutic

Pharmaceutical ManufacturingUnited States51-200 Employees

Oral integrin therapies for patients with immunological, fibrotic, neoplastic and vascular diseases.

Morphic Tx is joining a three decade quest led by our scientific founder, Tim Springer, who initially discovered the integrin receptor family in the 1980s. This receptor family is an important drug target that has fueled the successful development of six injectable therapies approved for treatment of multiple sclerosis, ulcerative colitis, Crohn's disease, plaque psoriasis, acute coronary syndrome and complications during percutaneous coronary intervention.

Despite blockbuster commercial success, integrins have remained out of reach as small molecule drugs...until now.

Section iconCompany Overview

Headquarters
35 Gatehouse Drive, A2, Waltham, MA 02451 Waltham, MA 02451, US
Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $276M

    Morphic Therapeutic has raised a total of $276M of funding over 5 rounds. Their latest funding round was raised on May 03, 2023 in the amount of $276M.

  • $10M$50M

    Morphic Therapeutic's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $276M

    Morphic Therapeutic has raised a total of $276M of funding over 5 rounds. Their latest funding round was raised on May 03, 2023 in the amount of $276M.

  • $10M$50M

    Morphic Therapeutic's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.